August 2021 – ContextVision

In the Pan-European multicenter clinical study FirstPath, INIFY Prostate produced highly accurate, robust and homogenous results at all sites

ContextVision, Digital Pathology, Export, Home, Investor News, News, Patologi 2021-08-31

STOCKHOLM – August 31, 2021 – ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today announced that results from FirstPath – a European multicenter clinical study evaluating performance of INIFY® Prostate in routine clinical practice – were presented at the European Congress of Pathology by […]

ContextVision: Assessing a Digital Pathology spin-off with a listing on Euronext Growth

ContextVision, Home, Investor News, News 2021-08-26

STOCKHOLM – August 26, 2021 – ContextVision, a medical technology software company specializing in image processing and decision support tools within digital pathology, today announces that the Board of Directors of ContextVision is conducting a review of the company’s structure, and has initiated work assessing a spin-off of the Digital Pathology unit with a goal […]

ContextVision Webcast Q2 2021

Webcast 2021-08-12

Best ever sales within Medical Imaging and rewarding feedback from INIFY Prostate evaluations

ContextVision, Financial reports, Home, Investor News, News 2021-08-12

ContextVision delivered the Company’s best ever second quarter within Medical Imaging. Initial response from the ongoing clinical trials with the Company’s first digital pathology product, INIFY Prostate, are very promising.